These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 25951927

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. A novel dissolution method relevant to intestinal release behaviour and its application in the evaluation of modified release mesalazine products.
    Schellekens RC, Stuurman FE, van der Weert FH, Kosterink JG, Frijlink HW.
    Eur J Pharm Sci; 2007 Jan; 30(1):15-20. PubMed ID: 17085024
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis.
    Frieri G, Giacomelli R, Pimpo M, Palumbo G, Passacantando A, Pantaleoni G, Caprilli R.
    Gut; 2000 Sep; 47(3):410-4. PubMed ID: 10940280
    [Abstract] [Full Text] [Related]

  • 45. New oral salicylates in the therapy of chronic idiopathic inflammatory bowel disease.
    Robinson MG.
    Gastroenterol Clin North Am; 1989 Mar; 18(1):43-50. PubMed ID: 2646221
    [Abstract] [Full Text] [Related]

  • 46. Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis.
    Sandborn WJ, Regula J, Feagan BG, Belousova E, Jojic N, Lukas M, Yacyshyn B, Krzeski P, Yeh CH, Messer CA, Hanauer SB.
    Gastroenterology; 2009 Dec; 137(6):1934-43.e1-3. PubMed ID: 19766640
    [Abstract] [Full Text] [Related]

  • 47. Topical and systemic availability of 5-aminosalicylate: comparisons of three controlled release preparations in man.
    Christensen LA, Fallingborg J, Abildgaard K, Jacobsen BA, Sanchez G, Hansen SH, Bondesen S, Hvidberg EF, Rasmussen SN.
    Aliment Pharmacol Ther; 1990 Oct; 4(5):523-33. PubMed ID: 2129640
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Xylan from Pineapple Stem Waste: a Potential Biopolymer for Colonic Targeting of Anti-inflammatory Agent Mesalamine.
    Anindya AL, Oktaviani RD, Praevina BR, Damayanti S, Kurniati NF, Riani C, Rachmawati H.
    AAPS PharmSciTech; 2019 Feb 13; 20(3):112. PubMed ID: 30761441
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Validation of a pharmacokinetic model of colon-specific drug delivery and the therapeutic effects of chitosan capsules containing 5-aminosalicylic acid on 2,4,6-trinitrobenzenesulphonic acid-induced colitis in rats.
    Tozaki H, Fujita T, Odoriba T, Terabe A, Okabe S, Muranishi S, Yamamoto A.
    J Pharm Pharmacol; 1999 Oct 13; 51(10):1107-12. PubMed ID: 10579681
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Physiological bicarbonate buffers: stabilisation and use as dissolution media for modified release systems.
    Fadda HM, Merchant HA, Arafat BT, Basit AW.
    Int J Pharm; 2009 Dec 01; 382(1-2):56-60. PubMed ID: 19666093
    [Abstract] [Full Text] [Related]

  • 56. A new 5-aminosalicylic acid multi-unit dosage form for the therapy of ulcerative colitis.
    Rudolph MW, Klein S, Beckert TE, Petereit H, Dressman JB.
    Eur J Pharm Biopharm; 2001 May 01; 51(3):183-90. PubMed ID: 11343881
    [Abstract] [Full Text] [Related]

  • 57. Eudragit FS 30 D: a new pH-sensitive polymer covering for mesalamine.
    Potestà P.
    Eur Rev Med Pharmacol Sci; 2001 May 01; 5(1):30. PubMed ID: 11860220
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.